Table 1.
Clinical features of exertional heat stroke, 2008–2010 cohort with questionnaire.
Table 2.
In vitro contracture test status, 2004–2010 cohort.
Table 3.
Exertional heat stroke recurrence, 2008–2010 cohort with questionnaire.
Fig 1.
In vitro contracture test response for malignant hyperthermia and malignant hyperthermia-susceptible EHS patients.
In vitro muscle bundle contracture force (g) for halothane and caffeine among malignant hyperthermia patients (left) and among IVCT-diagnosed malignant hyperthermia-susceptible patients with a history of exertional heat stroke (right) (p<0.0001 for halothane and caffeine). Abbreviations: IVCT, in vitro contracture test; EHS, exertional heat stroke.